This study tested an oral drug called LPCN 1154A in 90 women with severe postpartum depression. The goal was to see if it reduces depressive and anxiety symptoms better than a placebo. Participants took the drug or a placebo and were monitored for side effects and mood changes us…
Phase: PHASE3 • Sponsor: Lipocine Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC